Abstract
Obesity is a highly heritable and genetically heterogeneous disorder1. Here we investigated the contribution of copy number variation to obesity in 300 Caucasian patients with severe early-onset obesity, 143 of whom also had developmental delay. Large (>500 kilobases), rare (<1%) deletions were significantly enriched in patients compared to 7,366 controls (P < 0.001). We identified several rare copy number variants that were recurrent in patients but absent or at much lower prevalence in controls. We identified five patients with overlapping deletions on chromosome 16p11.2 that were found in 2 out of 7,366 controls (P < 5 × 10-5). In three patients the deletion co-segregated with severe obesity. Two patients harboured a larger de novo 16p11.2 deletion, extending through a 593-kilobase region previously associated with autism2,3,4 and mental retardation5; both of these patients had mild developmental delay in addition to severe obesity. In an independent sample of 1,062 patients with severe obesity alone, the smaller 16p11.2 deletion was found in an additional two patients. All 16p11.2 deletions encompass several genes but include SH2B1, which is known to be involved in leptin and insulin signalling6. Deletion carriers exhibited hyperphagia and severe insulin resistance disproportionate for the degree of obesity. We show that copy number variation contributes significantly to the genetic architecture of human obesity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fnature08689/MediaObjects/41586_2010_Article_BFnature08689_Fig1_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fnature08689/MediaObjects/41586_2010_Article_BFnature08689_Fig2_HTML.jpg)
Similar content being viewed by others
References
Friedman, J. M. Obesity in the new millennium. Nature 404, 632–634 (2000)
Kumar, R. A. et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet. 17, 628–638 (2008)
Weiss, L. A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667–675 (2008)
Marshall, C. R. et al. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82, 477–488 (2008)
Bijlsma, E. K. et al. Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. Eur. J. Med. Genet. 52, 77–87 (2009)
Ren, D. et al. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J. Clin. Invest. 117, 397–406 (2007)
Walley, A. J., Asher, J. E. & Froguel, P. The genetic contribution to non-syndromic human obesity. Nature Rev. Genet. 10, 431–442 (2009)
Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889–894 (2007)
Dina, C. et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nature Genet. 39, 724–726 (2007)
Willer, C. J. et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nature Genet. 41, 25–34 (2009)
Thorleifsson, G. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nature Genet. 41, 18–24 (2009)
Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085–1095 (2003)
Farooqi, I. S. et al. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N. Engl. J. Med. 356, 237–247 (2007)
Lee, J. A. & Lupski, J. R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 52, 103–121 (2006)
Korn, J. M. et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nature Genet. 40, 1253–1260 (2008)
Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232–236 (2008)
Fernandez, B. A. et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J. Med. Genet 10.1136/jmg.2009.069369 (15 September 2009)
Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445–449 (2007)
Sharp, A. J. et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nature Genet. 40, 322–328 (2008)
van Bon, B. W. et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J. Med. Genet. 46, 511–523 (2009)
Poot, M. et al. Recurrent copy number changes in mentally retarded children harbour genes involved in cellular localization and the glutamate receptor complex. Eur. J. Hum. Genet 10.1038/ejhg.2009.120 (22 July 2009)
Ren, D., Li, M., Duan, C. & Rui, L. Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice. Cell Metab. 2, 95–104 (2005)
Hirschhorn, J. N. & Altshuler, D. Once and again—issues surrounding replication in genetic association studies. J. Clin. Endocrinol. Metab. 87, 4438–4441 (2002)
Morris, D. L., Cho, K. W., Zhou, Y. & Rui, L. SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of IRS proteins. Diabetes 58, 2039–2047 (2009)
Loos, R. J. et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nature Genet. 40, 768–775 (2008)
Acknowledgements
We thank the patients, their families and all the Physicians who have referred patients to the Genetics of Obesity Study (GOOS). E.G.B., N.H., M.E.H. (grant no. 077014/Z/05/0Z) and I.S.F. (grant no. 082390/Z/07/Z) were funded by the Wellcome Trust. I.S.F. and S.O.R. are funded by the MRC Centre for Obesity and Related Disorders and NIHR Cambridge Biomedical Research Centre. We would like to thank L. Mavrogiannis for advice on MLPA analysis and V. Trowse for help with clinical studies. This study makes use of control data provided by the Genetic Association Information Network (GAIN) and the Wellcome Trust Case Control Consortium 2 (WTCCC2), through work funded by NIH and the Wellcome Trust (under award 085475). The GAIN General Research Use data sets used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP; http://www.ncbi.nlm.nih.gov/gap, dbGaP accession numbers phs000017 and phs000021). A full list of the investigators who contributed to the generation of the WTCCC2 data is available from http://www.wtccc.org.uk/ccc2.
Author Contributions I.S.F., M.E.H., E.G.B. and N.H. designed the study, analysed the data and wrote the paper. All the authors contributed to data collection and/or processing, as well as the current version of the paper.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Figures I & 3-10 with Legends, Legend for Supplementary Figure 2, Supplementary Notes and Supplementary Tables 1-5. (PDF 1670 kb)
Supplementary Figure
This file contains Supplementary Figure 2 (for Legend see Supplementary Information file). (PDF 2068 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bochukova, E., Huang, N., Keogh, J. et al. Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463, 666–670 (2010). https://doi.org/10.1038/nature08689
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature08689
This article is cited by
-
Metabolic effects of the schizophrenia-associated 3q29 deletion
Translational Psychiatry (2022)
-
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
Nature Reviews Endocrinology (2022)
-
Association of 3-hydroxy-3-methylglutaryl-coenzyme A reductase gene polymorphism with obesity and lipid metabolism in children and adolescents with autism spectrum disorder
Metabolic Brain Disease (2022)
-
SH2B1 variants as potential causes of non-syndromic monogenic obesity in a Brazilian cohort
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity (2022)
-
Targeting the RHOA pathway improves learning and memory in adult Kctd13 and 16p11.2 deletion mouse models
Molecular Autism (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.